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Standards Initiative ? 2007 ????????????????????????
??????????????????? 4?? (Identified compound, Putatively 
annotated compound, Putatively characterized compound, Unknown compound) 
2 
?????? 20)????????????? Identified compound????????
????????? 2????????????????????????????







??????? (gas chromatography, GC) ???????????? (liquid 



































???????????????? The NIST 14 Mass Spectral Library (???
NIST14) ? GC/MS??? 242,477????????? 276,259????????
??????????????????????????????????????








???????? 51,216 ????????????????????7,692 ???
????? 14,835????????? 183,068????????????????
??????????????????????????????? LC/MS???

















Table 1-1 ??????????? LC/MS?????? 
 
Compounds with  
MS/MS Spectrum Spectra Reference 
NIST14 8,171 (ion trap)  7,692 (collision cell)  
51,216 (ion trap)  
183,068 (collision cell)  
25) 
METLIN 12,107 62,112 26) 
Wiley Registry MSMS 1,208 12,122 27) 
HMDB*1 1579 2741 (ion trap)  1218 (collision cell)  
28) 
MassBank*2 - 21,971 29,30) 
*1: Human metabolome database???Web????????????????? 





PubChem???? National Institutes of Health (NIH) ? U.S. National Library 
of Medicine (NLM) ???????National Center for Biotechnology Information 
(NCBI) ????????????????????????2015 ? 1 ?????
5100?????????? (???????????????) ??????? 31)?
???ChemSpider???? Royal Society of Chemistry (RSC) ?????????
???????????3200 ??????????? 32)????????????
Kyoto Encyclopedia of Genes and Genomes (KEGG)33) ? Human Metabolome 
Database (HMDB) ?????????????????????????????



































??????PubChem??? ChemSpider????? 5100???? 3200???
??????????????????????????????????????
??????? 23719? (PubChem) ??? 9556? (ChemSpider) ??????





















































































?? 9???? (5, 10, 15, 20, 25, 30, 35, 40, 45) ???????????LCMS?
??????????????????????????????????????
???Milli-Q Gradient ultrapure water system (Millipore?) ????? 
 
2.2.1.2. ????? 
???? (10 mg) ? 2 mL????????????????????????
??????????? (Retsch?) ???????????????????? 1 
mL??????/?/?????? (2.5/1/1 (v/v/v) ) ?????37°C?? 30???
????????????1,6000 g?? 10????????????200 μL???
? 150 μL?????????????????????????????-80°C?
??????200 μL??????/?/?? (80/20/0.1 (v/v/v) ) ???????0.2 μm 





???? MSn ???????????? -?????????????
LCMS-IT-TOF (?????? ) ??????????????? Prominence 
UFLC (??????) ???????????? Shim-Pack XR-ODS (50 mmL. x 2 
mmID., 2.2 μm???????) ??????????????? 40°C?????
??? 0.1 %????? (A) ???????? (B) ??????? 0.4 mL/min?
??????????????? 2%B (0.00 min) , 60%B (10.00 min) , 98%B 
(10.01-14.00 min) , 2%B (14.01 min) , STOP (19.00 min) ????????????
??????????????????????????? ESI?????????
???? (N2) ??? 1.5 L/min???????? 0.1 MPa??????+4.5 / -3.5 kV?
CDL ??? 200°C??????????? 200°C ???????????? m/z 
100-1000????????????10 msec (MS1) ???30 msec (MS2-3) ????
MS2-3???????????????????????????????????






latent structures by means of partial least squares (PLS) ???????????








??? Formula Predictor?????????Formula Predictor?????? m/z
??????????????????????????????????????
?????????????? 45)??????? formula score???????? 3
????????????????????? ChemSpider???????????
???????????????????????? ChemSpider ?????
Application Programming Interface (API) ??? Visual Basic?????????
? 4????????????????????????????ACD/MS manager
??????????????????????????????????????
?????????????????? Assignment Score? Eq.2-1???????




Fig. 2-1 ACD/MSmanager?????????????? 
13 
𝐴𝑠𝑠𝑖𝑔𝑛𝑚𝑒𝑛𝑡 𝑆𝑐𝑜𝑟𝑒=  ∑ ூ௡௧௘௡௦௜௧௬ೌ೔ೌ೔∑ ூ௡௧௘௡௦௜௧௬೚೔೚೔   (Eq. 2-1)  








?????????????????????10, 20, 30, 40, 50 eV???????
??????????????????????????????????????




















????????????? formula score?spectrum score???? penalty score
??? 3 ????????????ACD/MS manager ????????????
formula score ? assignment score ???????spectrum score ? assignment 
score ????? Eq. 2-1 ?????????????????????? penalty 
score?????????????????????penalty score? penalty value
???????????penalty value? Hill and Mortishire Smith? 46)????
?????????????? Ridder?????????? 43)?????? ketone 
bond??????? penalty score???? (Eq. 2-3)?penalty score? 0?? 100
??????????? penalty score????????????????????
?? penalty score?????????????????????????????
penalty score??????????????????? penalty score??????
???penalty score ????????????????????????????




????? ”lowest lank” ??????????????????? 5%?????
???????????????? 𝑝𝑒𝑛𝑎𝑙𝑡𝑦 𝑠𝑐𝑜𝑟𝑒= ቀ1 − ∑ ௉௏೔×ோூ೔೔௡×௉௏ౣ ౗౮×ଵ଴଴ቁ × 100  (Eq. 2-2)  
 
 𝑝𝑒𝑛𝑎𝑙𝑡𝑦 𝑣𝑎𝑙𝑢𝑒= ∑ ℎ௕𝑝௕௕∈ௗ௜௦௦௖௢௡. ௕௢௡ௗ   (Eq. 2-3)  
  
Where 
single bond: p=1 bond including non-carbon: h=1 
double bond: p=2 carbon-carbon bond: h=2 
triple bond: p=3 keton bond: h=3 
𝑖 ∈ 𝑝𝑟𝑜𝑑𝑢𝑐𝑡 𝑖𝑜𝑛 Where 
PVi: minimum penalty value for each product ion 
RIi: relative intensity (%) of each product ion 






???????? LCMS-IT-TOF ??????????????? (UHPLC) ?







???????????? 10 Hz????????????? UHPLC?????
?????????? 























?? Testing Set ?????? Training Set????????????? (Fig. 2-3)?
Fig.2-3a????Observed vs Predicted Plot?????????????????






Fig. 2-3 ??????????????????????  
a) ???????????????????????????? b) ??????????????











































































































































































 Fig. 2-4 UK-001?????MSn?????? 
??????? 
?????????????????????????????????????









assignment score??? (Eq. 2-1)??????????????????????
??????????????????????????????????????








Fig. 2-5 UK-001?????????? ACD MS/manager????????? 





??????????????? assignment score 85.6?????? 8????? 




????????? (Fig. 2-6)??????? formula score??????????
22 
????? formula score? assignment score????????????2????
????????????????? final score?????????6??????













score formula compound name 
58567 85.6 C22H18O10 Catechingallate 
97034 85.6 C22H18O10 (2R, 3R)-2-(3, 4-Dihydroxyphenyl)-5, 7- dihydroxy-3, 4-dihydro-2H-chromen-3-yl 3, 4, 5-trihydroxybenzoate 
325907 85.6 C22H18O10 (-) – Epicatechingallate 
4440417 85.6 C22H18O10 
Benzoic acid, 3, 4, 5-trihydroxy-,  (2R, 3S)-2-(3, 
4-dihydroxyphenyl)-3, 4-dihydro-5, 7- 
dihydroxy-2H-1-benzopyran-3-yl ester 
4925466 85.6 C22H18O10 (2S, 3R)-2-(3, 4-dihydroxyphenyl)-5, 7- dihydroxy-3, 4-dihydro-2H-chromen-3-yl 3, 4, 5- trihydroxybenzoate 
9434303 85.6 C22H18O10 (2R, 3R)-2-(3, 5-dihydroxyphenyl)-5, 7- dihydroxy-3, 4-dihydro-2H-chromen-3-yl 3, 4, 5- trihydroxybenzoate 
338663 85.6 C16H19N4O9P methyl (1-amino-2-phenylethyl) methylphosphinate-2, 4, 6-trinitrophenol (1:1) 












Fig. 2-7 UK-004????????????? ChemSpiderID 
 
VIP ?????????? 20 ???????????????????????




?????? (Fig. S-2)?Caffeine? Catechin????????????????
????????????UK-006?????????????Theogallin?Quinic 




??????? 49)????UK-001??????? final score? 94.24?????






Pongsuwan et al.????????????? LC/MS?????????????








Table 2-3 VIP?????????????????????? 20??????????? 
ID m/z R.T.  (min)  
VIP 
value Candidate  Formula Ion 
Final 
score 
UK-001 195.087 4.807 7.448 caffeine and 11 analogue C8H10N4O2 [M+H]+ 94.24 
UK-002 307.080 4.063 6.230 gallocatechin and 10 analogue C15H14O7 [M+H]+ 87.86 
UK-003 459.092 5.156 5.023 gallocatechin gallate and seven analogue C22H18O11 [M+H]+ 93.07 
UK-004 443.097 6.392 4.902 catechin gallate and five analogue C22H18O10 [M+H]+ 89.95 
UK-005 261.169 5.429 4.627 1-(4-amino-6,7,8,9-tetrahydro-1h-imidazo[4,5-c]quinolin-1-yl) -2-methylpropan-2-ol C14H20N4O [M+H]
+ 73.06 
UK-006 345.080 1.003 4.321 theogalline and three analogue C14H16O10 [M+H]+ 93.84 
UK-007 339.106 5.719 3.029 coumaroyl quinic acid and six analogue C16H18O8 [M+H]+ 82.14 
UK-008 217.068 4.805 2.746  (Sodium ion adduct of UK-001)   (not calculated)  
UK-009 261.169 4.034 2.547 1-(4-amino-6,7,8,9-tetrahydro-1h-imidazo[4,5-c]quinolin-1-yl) -2-methylpropan-2-ol  C14H20N4O [M+H]
+ 75.44 
UK-010 361.088 5.717 2.298  (Sodium ion adduct of UK-007)   (not calculated)  
UK-011 273.074 6.393 2.205  (Fragment of UK-004)   (not calculated)  




C14H24N2O9 [M+H]+ 58.90 
UK-013 291.086 3.958 2.184 catechin / epicatechin C15H14O6 [M+H]+ 93.65 
UK-014 417.172 6.971 2.181 3-[[4-(2,4-dimethylphenyl)-5-(1-naphthylmethyl)-1,2,4-triazol-3-yl]sulfanyl]propanamide C24H24N4OS [M+H]
+ 59.30 
UK-015 275.185 5.841 2.178 [4-amino-1-(2-methylpropyl)-6,7,8,9-tetrahydro-1h-imidazo[4,5-c]quinolin-2-yl]methanol C15H22N4O [M+H]
+ 76.53 
UK-016 181.072 2.541 2.158 4-hydroxy-6-methyl-3,4-dihydropteridin-2(1H) –one C7H8N4O2 [M+H]+ 86.80 




C21H20O11 [M+Na]+ 84.23 




C26H28O14 [M+H]+ 53.25 





C30H26O12 [M+H]+ 64.55 
UK-020 307.083 1.834 1.597 gallocatechin / epigallocatechin C15H14O7 [M+H]+ 87.86 
 
 
Table 2-4 ??????????????????????????????????? 
ID Identified compound 
# of queried candidates # of final 
candidates* m/z value +/- 5 mDa 
Formula 
 (MS1)  
Formula 
 (MSn)  
UK-001 caffeine 1168 408 214 15 
UK-002 gallocatechin 2191 177 177 18 
UK-003 epigallocatechin gallate 1657 140 140 10 
UK-004 epicatechin gallate 2104 213 79 7 
UK-013 catechin 2905 394 322 30 







2.3.1 ???????????????????????? ACD/MS manager ?
?????ACD/MS manager????????????????????????
??????????????????????????????????????





































?????????????????????????? (Eq. 2-2?Eq. 2-3)? 
penalty value???????????????????????penalty value??
????????? penalty value??????????????????????
??????????????Eq. 2-2 ????????? penalty score ????
ChemProphet ???????????????????????????????
?? (formula score) ????????????? (spectrum score) ??????
????? (penalty score) ?????????????????????????







??????????????????????????? Hill ???? 41)???
?? PubChem?????? (?? Table S-1)?????????? 372.5 +/- 11.1
??????????? 
????????????????????????30%???????????








?????????? (?? Table S-2, S-3)?????4-Aminoantipyrine????









































Table 2-5 ??????????????????????????????????? 
Compound PubChem comp. ID MIMW 




Rank of  
compound 
4-Aminoantipyrine 2151 203.1059 13 221 3 
6a-Methylprednisolone 4159 374.2093 8 176 7 
Acepromazine 6077 326.1453 4 271 2 
Acetophenazine 441185 411.198 7 408 2 
Adenosine_Diphosphate 197 427.0294 3 31 2 
Adiphenine 2031 311.1885 6 577 8 
Albuterol 2083 239.1521 4 213 12 
Alfentanil 51263 416.2536 8 158 1 
Amfenac 2136 255.0895 9 279 2 
Aminophylline 2153 180.0647 3 61 5 
Ampicillin 2174 349.1096 11 560 2 
Anileridine 8944 352.2151 2 514 2 
Antipyrine 2206 188.095 28 282 233 
Apomorphine 2215 267.1259 5 411 5 
Apramycin 71428 539.2803 8 50 1 
Betaxolol 2369 307.2147 15 175 1 
Boldenone_Undecylenate 25702 452.329 12 20 8 
Bumetanide 2471 364.1093 14 569 41 
Buprenorphine 2476 467.3036 22 32 1 
Buspirone 2477 385.2478 7 20 1 
Cholesterol 304 386.3549 3 41 26 
Cromolyn 2882 468.0693 4 30 3 
Cymarin 539061 548.2985 12 43 1 
Daunorubicin 2958 527.1791 6 95 7 
Dextromethorphan 3008 271.1936 13 137 19 
Dihydroergotamine 3066 583.2795 11 31 4 
Dimefline 3078 323.1521 6 534 5 
Diphenoxylate 13505 452.2464 25 292 44 
Dobutamine 36811 301.1678 7 385 8 
Doxorubicin 1691 543.1741 6 55 7 
Drofenine 3166 317.2355 6 104 1 
Enalapril 3222 376.1998 6 177 1 
Enalaprilat 5362033 348.1685 6 312 2 
Ephedrine 5032 165.1154 6 243 47 




Table 2-5 ??????????????????????????????????? (??)  
Compound PubChem comp. ID MIMW 




Rank of  
compound 
Etamiphylline 28329 279.1695 13 43 1 
Etodolac 3308 287.1521 12 366 1 
Fenbendazole 3334 299.0728 3 378 88 
Fenoterol 3343 303.1471 4 308 3 
Folic_Acid 3405 441.1397 4 568 1 
Gallamine 3450 510.4635 4 7 1 
Gingerol 3473 294.1831 7 131 1 
Hematoporphyrin_I 11103 598.2791 15 39 4 
Hydrocortisone 3640 362.2093 46 209 9 
Hydroxybutorphanol 3064246 343.2147 8 34 19 
Hydroxyphenethylamine 5610 137.0841 6 166 6 
Isoxsuprine 3783 301.1678 10 37.5 2 
Ketorolac 3826 255.0895 4 279 73 
Leucine_Enkephalin 3903 555.2693 19 51 2 
Mebeverine 4031 429.2515 3 78 2 
Mefenamic_Acid 4044 241.1103 6 512 18 
Meprobamate 4064 218.1267 3 76 6 
Methionine_Enkephalin 42785 573.2257 11 55 1 
Methotrexate 4112 454.1713 3 585 7 
Methylergonovine 4140 339.1947 14 468 9 
Morphine-3-glucuronide 4318740 461.1686 2 102 3 
Naltrexone 4428 341.1627 5 878 48 
Nandrolone 9904 274.1933 48 84 21 
Nimesulide 4495 308.0467 14 122 70 
Norpropoxyphene 18804 325.2042 3 352 11 
Noscapine 4544 413.1475 12 222 1 
Ormetoprim 23418 274.143 5 238 4 
Oxaprozin 4614 293.1052 7 426 6 
Oxybutynin 4634 357.2304 28 80 1 
Oxycodone 4635 315.1471 4 695 84 
Oxytetracycline 5280972 460.1482 10 1511 5 
Perindopril 107807 368.2311 4 55 1 
Piperacetazine 19675 410.2028 4 434 1 
Poldine 11018 340.1913 - - - 
-: not assigned   
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Table 2-5 ??????????????????????????????????? (??)  
Compound PubChem comp. ID MIMW 




Rank of  
compound 
Prazosin 4893 383.1594 11 141 2 
Prednisolone 4894 360.1937 11 211 16 
Prednisolone_Tebutate 4898 458.2668 13 130 1 
Prednisone 4900 358.178 27 296 21 
Prolintane 14592 217.183 4 96 3 
Pyrilamine 4992 285.1841 3 247 1 
Remifentanil 60815 376.1998 12 177 1 
Reserpine 5052 608.2734 8 23 2 
Rolitetracycline 54682938 527.2268 3 454 3 
Salmeterol 5152 415.2723 6 22 1 
Spectinomycin 2021 332.1584 56 274 1 
Streptomycin 19649 581.2657 15 30 1 
Strychnine 5304 334.1681 42 589 245 
Strychnine_N-oxide 73393 350.163 21 1088 2 
Sufentanil 41693 386.2028 6 403 1 
Sulfadimethoxine 5323 310.0736 10 86 5 
Sulfasalazine 5384001 398.0685 11 95 8 
Taurocholate 8959 515.2917 7 47 4 
Tenoxicam 5282194 337.0191 8 109 6 
Terbutaline 5403 225.1365 5 162 11 
Terfenadine 5405 471.3137 3 29 2 
Testosterone_Propionate 5995 344.2351 10 89 3 
Tetracaine 5411 264.1838 5 291 1 
Tetracycline 54675776 444.1533 11 1570 17 
Tetramisole 3913 204.0721 16 105 57 
Theobromine 5429 180.0647 16 82 21 
Thiethylperazine 5440 399.1803 8 473 7 
Thioridazine 5452 370.1537 8 760 1 
Thiothixene 941651 443.1701 28 630 1 
Thonizide 5456 511.4376 4 4 1 
Tripelennamine 5587 255.1735 4 92 1 




Table 2-6 ??????????????????????????????? 
 ChemProphet Hill et al.
a)  Wolf et al.a)  Ridder et al.b)  
Product ion merged selected merged merged 
Average rank 14.7 (+/- 3.6)  44.2 (+/- 14.1)  24 (+/- 7.9)  30.8 (+/- 9.8)  
Std. deviation 36.6 142.5 80.2 98.9 
Median rank 3 4 4.5 3 
3rd quartile rank 8 17.5 11.75 9 
a) Rank for each candidate were supplied as additional file published by Wolf et al. 
b) Rank for each candidate were supplied as supporting information published by Ridder et al. 
 
Table 2-7 ???????????????????????????????? 
 ChemProphet Wolf et al. Ridder et al. 
Product ion merged merged merged 
Average 24106.5 (+/- 14328.3) 486.9 (+/- 98.3) 1260.6 (+/- 175.3) 
Std. Deviation 144708.8 992.5 1770.0 
25% Quartile 29.9 133.3 229.4 
Median 281.5 206.5 526.7 
75% Quartile 2792.2 457.0 1200.8 
(???milli second/candidate)   
 
  


































































????? 52)??????????? CID ??????????????????
??????????????????????????????????????




















?????????????Milli-Q Gradient ultrapure water system (Millipore




??????/???????/?? (100/100/0.1 (v/v/v) ) ????????????
???????????(??? ???????)???????????????





7 ??? Jcl:ICR ??? 8 ?????? (CE-2) ??????????????
??????????? 4 ??????????? 4 ?? 2 ??????????
28.6 – 32.5 g????????????????????????????????
?????????????????? 18 ??????????????????





??????????????? 300 μL???????? 300 μL??????





???? MSn ???????????? -?????????????
LCMS-IT-TOF (??????) ???????????????Nexera X2 (???
???) ????? 
?????-3 ??????? MSn ????????????????????
??????????????????????????/???????/?? 
(100/100/0.1 (v/v/v) ) ??????? 0.2 mL/min???????????????
?? 4°C????????? 5 μL??????????????????????
?????????? ESI????????????? (N2) ??? 1.5 L/min??
41 
?????? 0.1MPa??????-3.5 kV?CDL??? 200°C?????????
?? 200°C????????????m/z 100-1000????????????MS1
?????MSn?? (n ≥ 2) ???????? 10 msec ??? 30 msec ????
MSn????????????? Data dependent analysis?? (DDA) ?????
?????????MS1?????????????????????????MS2
????????????????????MSn-1 (n ≥ 2) ????????????
????????????? 80 u??????????????????????
????? 176u????????????????????MSn (n ≥ 2) ????
?????????????????????????????????????
Automatic sensitivity control??????? 
?????????????????????????????????
Shim-pack XR-ODSII (75 mm L  2.0 mm I.D., 2.2 μm, ??????) ?????
?????????? 40°C ?????????? 10 mmol/L ?????????
?? (A) ????????? (B) ??????? 0.25 mL/min?????????
??????? 0%B (0.0-3.0 min) , 30 %B (15.0 min) , 98%B (23.0-25.0 min) , 0%B 






Solution (??????) ???????????? PLS??????? OPLS??
????????????? SIMCA-P+ ver.12.0 (Umetrics?) ?????????






??????????MSn (n ≥ 2) ??????????????????????
??????????????????????????? ChemSpider?????











































Fig. 3-1 ????????????????????????????????????? 
 
3.2.8. Quercetin 3-glucuronide??????????????? 
????????????????????????????????????
?????????-3?????? (quercetin 3-glucuronide) ?????????
??????????MS1 ????????????????????? m/z 
477.0680 ?????????????????????????????????
?MS2??????m/z 301.0354????????????????????? 176 
u?????????????????????????????????????
????????????????????? 0.1 mDa??? 0.2 ppm?????
???????DDA??????????????????????MS3????
?????????????????????????????????MS1-3??












????????????????? 5??????Fig. 3-3???????m/z 107




Fig. 3-2 ???????????? quercetin 3-glucuronide???????????? 
46 
 
Fig. 3-3 quercetin glucuronide???? 5??????????????? 









???????????? 80 u?????? 3????????????????
MS5??????? 
???????????????????? 4???? 24???????????
??????????? (n=3) ?????? 12?????????Fig. 3-4???
?????? TIC ????????????? 12 ?????????? Profiling 
Solution???? 3105???????????????????????????




Fig. 3-4 ????????? TIC??????? 




Fig. 3-5 ????????????? OPLS?????? 
a) score plot?b) S-plot? 
 










? ? ? MS3 ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
di-hydroxyphenyl-γ-valerolactone ??????? 6???????MS2?????
?????????????????????? di-hydroxyphenyl-γ-valerolactone






???????m/z 287????? di-hydroxyphenyl- γ-valerolactone-O-sulfate?
???????????? 






?????Fig. 3-7???? catechin??????catechin-O-sulfate ?? 5???
?????????????????????????????????????B
?? 3?????? 4?????????????????????????? (Fig. 
3-8)????????? catechin???????????????????????




??????3’??? 4’-O-sulfate ???????????m/z 231???????
???5??? 7-O-sulfate???m/z 247?????????? 62)???????
???????????????m/z 231???????m/z 247????????
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???????????????????C11H12O7S ??? C16H16O10S ?????
???????????di–hydroxyphenyl–γ–  valerolactone-O-sulfate ???
O-methyl-gallocatechin-O-sulfate ??????ChemSpider ??????????
???????????C15H14O9S ????????catechin-O-sulfate?????
?? C-sulfate ?????????????????? O-sulfate ????????














Table. 3-1 ????????????? 
 m/z 287 m/z 369 m/z 399 m/z 481 
Conjugation sulfate sulfate sulfate glucuronide 
Formula 
 (conjugate)  C11H12O7S C15H14O9S C16H16O10S C21H22O13 
Formula 






valerolactone catechin O-methyl-gallocatechin Gallocatechin 




1 7 5 4 
# of Candidate 1015 412 514 203 








four isomers  
including 
candidate 
Predicted site of 








































































































????Table 4-1?????????????? C6H10O5????? 162 u???
?????????????????????? 64)???????????????
?????????????????????????????????????









































ChemSpider ???????????????????????? (a) ????
???????? (b) ??????ACD/MS manager?????? (c) ??????
??????????????????????????? final score ?????




??????? (JCAMP??) ???? (MDLmolfile??) ????????? (png??) ?
??????????????? ChemSpiderID??????????????????? 
 
 (???????)  





























Fig. S-2 ????????????? 
a) UK-001, b) UK-002, c) UK-003, d) UK-004, e) UK-005, f) UK-006, g) UK-007, h) UK-008, i) 
UK-009, j) UK-010, k) UK-011, l) UK-012, m) UK-013, n) UK-014, o) UK-015, p) UK-016, q) 
UK-017, r) UK-018, s) UK-019, and t) UK-020. 
  
1286 2424 85748 197908 527291 
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Fig. S-2 ????????????? (??)  
  
65231 136727 148659 
389677 432421 8058656 
8600662 9384021 1029015 












































































































d) UK-004 catechin gallate and five isomers. 
Fig. 2-7???. 
 





Fig. S-2 ????????????? (??)  
  
65231 136727 148659 








































































































































Fig. S-2 ????????????? (??)   
391291 405508 417242 36884404 













































































































































h) UK-008 (Sodium ion adduct of UK-001)  
 







j) UK-010 (Sodium ion adduct of UK-007)  
 
k) UK-011 (Fragment of UK-004)  
 































































Fig. S-2 ????????????? (??)  
  
1166 8711 65230 
65929 102562 158494 
224054 389678 8411902 























































































n) UK-014 2-{[4- (2,4-dimethylphenyl) -5- (naphthalen-1-ylmethyl) 


















































































































r) UK-018  









 (2r,3s) -2- (3,4-dihydroxyphenyl) -8-{2,3-dihydroxy-5-[ (2r,3s) 




















































































Fig. S-2 ????????????? (??)  
  
65231 136727 148659 
1211 58594 64694 
389677 432421 8058656 




























































































Table S-1 ???????????? 
Compound PubChem Query 
4-Aminoantipyrine (0000 : 2006/02[CreateDate]) AND (203.103830996379[MonoisotopicMass] : 203.107893113621[MonoisotopicMass]) 
6a-Methylprednisolone (0000 : 2006/02[CreateDate]) AND (374.205581979759[MonoisotopicMass] : 374.213066166241[MonoisotopicMass]) 
Acepromazine (0000 : 2006/02[CreateDate]) AND (326.14202257616[MonoisotopicMass] : 326.14854548184[MonoisotopicMass]) 
Acetophenazine (0000 : 2006/02[CreateDate]) AND (411.193935900521[MonoisotopicMass] : 411.202159861479[MonoisotopicMass]) 
Adenosine_Diphosphate (0000 : 2006/02[CreateDate]) AND (427.025144453853[MonoisotopicMass] : 427.033685042148[MonoisotopicMass]) 
Adiphenine (0000 : 2006/02[CreateDate]) AND (311.185417166709[MonoisotopicMass] : 311.191640937291[MonoisotopicMass]) 
Albuterol (0000 : 2006/02[CreateDate]) AND (239.149752024565[MonoisotopicMass] : 239.154535067435[MonoisotopicMass]) 
Alfentanil (0000 : 2006/02[CreateDate]) AND (416.249426389111[MonoisotopicMass] : 416.257751460889[MonoisotopicMass]) 
Amfenac (0000 : 2006/02[CreateDate]) AND (255.086992393567[MonoisotopicMass] : 255.092094184433[MonoisotopicMass]) 
Aminophylline (0000 : 2006/02[CreateDate]) AND (180.062924874745[MonoisotopicMass] : 180.066526169255[MonoisotopicMass]) 
Ampicillin (0000 : 2006/02[CreateDate]) AND (349.106135707732[MonoisotopicMass] : 349.113117900268[MonoisotopicMass]) 
Anileridine (0000 : 2006/02[CreateDate]) AND (352.211556002218[MonoisotopicMass] : 352.218600303782[MonoisotopicMass]) 
Antipyrine (0000 : 2006/02[CreateDate]) AND (188.09308206837[MonoisotopicMass] : 188.09684396763[MonoisotopicMass]) 
Apomorphine (0000 : 2006/02[CreateDate]) AND (267.123257535712[MonoisotopicMass] : 267.128600054288[MonoisotopicMass]) 
Apramycin (0000 : 2006/02[CreateDate]) AND (539.274864382428[MonoisotopicMass] : 539.285649987572[MonoisotopicMass]) 
Betaxolol (0000 : 2006/02[CreateDate]) AND (307.211671654562[MonoisotopicMass] : 307.217815949438[MonoisotopicMass]) 
Boldenone_Undecylenate (0000 : 2006/02[CreateDate]) AND (452.324521988547[MonoisotopicMass] : 452.333568569453[MonoisotopicMass]) 
Bumetanide (0000 : 2006/02[CreateDate]) AND (364.105651360076[MonoisotopicMass] : 364.112933545925[MonoisotopicMass]) 
Buprenorphine (0000 : 2006/02[CreateDate]) AND (467.298885774412[MonoisotopicMass] : 467.308231845588[MonoisotopicMass]) 
Buspirone (0000 : 2006/02[CreateDate]) AND (385.243922787247[MonoisotopicMass] : 385.251627742753[MonoisotopicMass]) 
Cholesterol (0000 : 2006/02[CreateDate]) AND (386.351002550339[MonoisotopicMass] : 386.358729647661[MonoisotopicMass]) 
Cromolyn (0000 : 2006/02[CreateDate]) AND (468.064580664386[MonoisotopicMass] : 468.073942049614[MonoisotopicMass]) 
Cymarin (0000 : 2006/02[CreateDate]) AND (548.29305002567[MonoisotopicMass] : 548.30401599633[MonoisotopicMass]) 
Daunorubicin (0000 : 2006/02[CreateDate]) AND (527.173874365538[MonoisotopicMass] : 527.184417948462[MonoisotopicMass]) 
Dextromethorphan (0000 : 2006/02[CreateDate]) AND (271.190902493856[MonoisotopicMass] : 271.196326366144[MonoisotopicMass]) 
Dihydroergotamine (0000 : 2006/02[CreateDate]) AND (583.273636529307[MonoisotopicMass] : 583.285302118693[MonoisotopicMass]) 
Dimefline (0000 : 2006/02[CreateDate]) AND (323.148912024565[MonoisotopicMass] : 323.155375067436[MonoisotopicMass]) 
Diphenoxylate (0000 : 2006/02[CreateDate]) AND (452.241855818217[MonoisotopicMass] : 452.250900745783[MonoisotopicMass]) 
Dobutamine (0000 : 2006/02[CreateDate]) AND (301.164781932064[MonoisotopicMass] : 301.170805287936[MonoisotopicMass]) 
Doxorubicin (0000 : 2006/02[CreateDate]) AND (543.168629038392[MonoisotopicMass] : 543.179492519608[MonoisotopicMass]) 
Drofenine (0000 : 2006/02[CreateDate]) AND (317.232306890208[MonoisotopicMass] : 317.238651599792[MonoisotopicMass]) 
Enalapril (0000 : 2006/02[CreateDate]) AND (376.19606002178[MonoisotopicMass] : 376.20358401822[MonoisotopicMass]) 
Enalaprilat (0000 : 2006/02[CreateDate]) AND (348.165040205781[MonoisotopicMass] : 348.172003576219[MonoisotopicMass]) 
Ephedrine (0000 : 2006/02[CreateDate]) AND (165.113712955359[MonoisotopicMass] : 165.117015262641[MonoisotopicMass]) 
Ergocristine (0000 : 2006/02[CreateDate]) AND (609.289026436806[MonoisotopicMass] : 609.301212339194[MonoisotopicMass]) 
Ergoloid_Mesylate (0000 : 2006/02[CreateDate]) AND (591.336156160304[MonoisotopicMass] : 591.347983001696[MonoisotopicMass]) 
Etamiphylline (0000 : 2006/02[CreateDate]) AND (279.166733248751[MonoisotopicMass] : 279.172316639249[MonoisotopicMass]) 
Etodolac (0000 : 2006/02[CreateDate]) AND (287.149272024565[MonoisotopicMass] : 287.155015067435[MonoisotopicMass]) 
Fenbendazole (0000 : 2006/02[CreateDate]) AND (299.069856638526[MonoisotopicMass] : 299.075838095474[MonoisotopicMass]) 
Fenoterol (0000 : 2006/02[CreateDate]) AND (303.144026697418[MonoisotopicMass] : 303.150089638582[MonoisotopicMass]) 
Folic_Acid (0000 : 2006/02[CreateDate]) AND (441.135269982186[MonoisotopicMass] : 441.144092775814[MonoisotopicMass]) 
Gallamine (0000 : 2006/02[CreateDate]) AND (510.458363173322[MonoisotopicMass] : 510.468572442678[MonoisotopicMass]) 
Gingerol (0000 : 2006/02[CreateDate]) AND (294.180167491907[MonoisotopicMass] : 294.186051154093[MonoisotopicMass]) 
Hematoporphyrin_I (0000 : 2006/02[CreateDate]) AND (598.27315218165[MonoisotopicMass] : 598.28511776435[MonoisotopicMass]) 
Hydrocortisone (0000 : 2006/02[CreateDate]) AND (362.205701979759[MonoisotopicMass] : 362.212946166241[MonoisotopicMass]) 
Hydroxybutorphanol (0000 : 2006/02[CreateDate]) AND (343.211311654562[MonoisotopicMass] : 343.218175949438[MonoisotopicMass]) 
Hydroxyphenethylamine (0000 : 2006/02[CreateDate]) AND (137.08269313936[MonoisotopicMass] : 137.08543482064[MonoisotopicMass]) 
Isoxsuprine (0000 : 2006/02[CreateDate]) AND (301.164781932064[MonoisotopicMass] : 301.170805287936[MonoisotopicMass]) 
Ketorolac (0000 : 2006/02[CreateDate]) AND (255.086992393567[MonoisotopicMass] : 255.092094184433[MonoisotopicMass]) 
Leucine_Enkephalin (0000 : 2006/02[CreateDate]) AND (555.263745875014[MonoisotopicMass] : 555.274851260986[MonoisotopicMass]) 
Mebeverine (0000 : 2006/02[CreateDate]) AND (429.247230723768[MonoisotopicMass] : 429.255815754232[MonoisotopicMass]) 
Mefenamic_Acid (0000 : 2006/02[CreateDate]) AND (241.107867628213[MonoisotopicMass] : 241.112689833787[MonoisotopicMass]) 
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Table S-1 ???????????? (??) 
Compound PubChem Query 
Meprobamate (0000 : 2006/02[CreateDate]) AND (218.124475810429[MonoisotopicMass] : 218.128838343571[MonoisotopicMass]) 
Methionine_Enkephalin (0000 : 2006/02[CreateDate]) AND (573.219986936808[MonoisotopicMass] : 573.231451451192[MonoisotopicMass]) 
Methotrexate (0000 : 2006/02[CreateDate]) AND (454.166774144841[MonoisotopicMass] : 454.175857571159[MonoisotopicMass]) 
Methylergonovine (0000 : 2006/02[CreateDate]) AND (339.191285115229[MonoisotopicMass] : 339.198069008771[MonoisotopicMass]) 
Morphine-3-Glucuronide (0000 : 2006/02[CreateDate]) AND (461.163969785185[MonoisotopicMass] : 461.173193156815[MonoisotopicMass]) 
Naltrexone (0000 : 2006/02[CreateDate]) AND (341.159296604918[MonoisotopicMass] : 341.166119859082[MonoisotopicMass]) 
Nandrolone (0000 : 2006/02[CreateDate]) AND (274.190538146199[MonoisotopicMass] : 274.196022011801[MonoisotopicMass]) 
Nimesulide (0000 : 2006/02[CreateDate]) AND (308.043611729078[MonoisotopicMass] : 308.049772662922[MonoisotopicMass]) 
Norpropoxyphene (0000 : 2006/02[CreateDate]) AND (325.200927074209[MonoisotopicMass] : 325.207431157791[MonoisotopicMass]) 
Noscapine (0000 : 2006/02[CreateDate]) AND (413.143320623479[MonoisotopicMass] : 413.151583572521[MonoisotopicMass]) 
Ormetoprim (0000 : 2006/02[CreateDate]) AND (274.140234413242[MonoisotopicMass] : 274.145717272758[MonoisotopicMass]) 
Oxaprozin (0000 : 2006/02[CreateDate]) AND (293.102262301067[MonoisotopicMass] : 293.108124404934[MonoisotopicMass]) 
Oxybutynin (0000 : 2006/02[CreateDate]) AND (357.226821563061[MonoisotopicMass] : 357.233966170939[MonoisotopicMass]) 
Oxycodone (0000 : 2006/02[CreateDate]) AND (315.143906697418[MonoisotopicMass] : 315.150209638582[MonoisotopicMass]) 
Oxytetracycline (0000 : 2011/12[CreateDate]) AND (460.143578898196[MonoisotopicMass] : 460.152781861804[MonoisotopicMass]) 
Perindopril (0000 : 2006/02[CreateDate]) AND (368.227439836779[MonoisotopicMass] : 368.234804459221[MonoisotopicMass]) 
Piperacetazine (0000 : 2006/02[CreateDate]) AND (410.198696880011[MonoisotopicMass] : 410.206900935989[MonoisotopicMass]) 
Poldine (0000 : 2006/02[CreateDate]) AND (340.187866793313[MonoisotopicMass] : 340.194670618687[MonoisotopicMass]) 
Prazosin (0000 : 2006/02[CreateDate]) AND (383.155522595458[MonoisotopicMass] : 383.163185782542[MonoisotopicMass]) 
Prednisolone (0000 : 2006/02[CreateDate]) AND (360.19007207226[MonoisotopicMass] : 360.19727594574[MonoisotopicMass]) 
Prednisolone_Tebutate (0000 : 2006/02[CreateDate]) AND (458.26225628361[MonoisotopicMass] : 458.27142162039[MonoisotopicMass]) 
Prednisone (0000 : 2006/02[CreateDate]) AND (358.174442164761[MonoisotopicMass] : 358.181605725239[MonoisotopicMass]) 
Prolintane (0000 : 2006/02[CreateDate]) AND (217.180877912503[MonoisotopicMass] : 217.185221573497[MonoisotopicMass]) 
Pyrilamine (0000 : 2006/02[CreateDate]) AND (285.181260534876[MonoisotopicMass] : 285.186964217124[MonoisotopicMass]) 
Remifentanil (0000 : 2006/02[CreateDate]) AND (376.19606002178[MonoisotopicMass] : 376.20358401822[MonoisotopicMass]) 
Reserpine (0000 : 2006/02[CreateDate]) AND (608.267298159191[MonoisotopicMass] : 608.279463626809[MonoisotopicMass]) 
Rolitetracycline (0000 : 2011/12[CreateDate]) AND (527.221492784349[MonoisotopicMass] : 527.232037319651[MonoisotopicMass]) 
Salmeterol (0000 : 2006/02[CreateDate]) AND (415.268105958413[MonoisotopicMass] : 415.276411403587[MonoisotopicMass]) 
Spectinomycin (0000 : 2006/02[CreateDate]) AND (332.155029551489[MonoisotopicMass] : 332.161672718511[MonoisotopicMass]) 
Streptomycin (0000 : 2006/02[CreateDate]) AND (581.259857097303[MonoisotopicMass] : 581.271482410698[MonoisotopicMass]) 
Strychnine (0000 : 2006/02[CreateDate]) AND (334.16478627972[MonoisotopicMass] : 334.17146964228[MonoisotopicMass]) 
Strychnine_N-oxide (0000 : 2006/02[CreateDate]) AND (350.159540952574[MonoisotopicMass] : 350.166544213426[MonoisotopicMass]) 
Sufentanil (0000 : 2006/02[CreateDate]) AND (386.198936880011[MonoisotopicMass] : 386.206660935989[MonoisotopicMass]) 
Sulfadimethoxine (0000 : 2006/02[CreateDate]) AND (310.070474913244[MonoisotopicMass] : 310.076676384757[MonoisotopicMass]) 
Sulfasalazine (0000 : 2006/02[CreateDate]) AND (398.064509586097[MonoisotopicMass] : 398.072470955903[MonoisotopicMass]) 
Taurocholate (0000 : 2006/02[CreateDate]) AND (515.286520577265[MonoisotopicMass] : 515.296826410735[MonoisotopicMass]) 
Tenoxicam (0000 : 2011/12[CreateDate]) AND (337.015727046028[MonoisotopicMass] : 337.022467427972[MonoisotopicMass]) 
Terbutaline (0000 : 2006/02[CreateDate]) AND (225.134242116065[MonoisotopicMass] : 225.138744845935[MonoisotopicMass]) 
Terfenadine (0000 : 2006/02[CreateDate]) AND (471.309016428704[MonoisotopicMass] : 471.318442703296[MonoisotopicMass]) 
Testosterone_Propionate (0000 : 2006/02[CreateDate]) AND (344.231702541551[MonoisotopicMass] : 344.238587244449[MonoisotopicMass]) 
Tetracaine (0000 : 2006/02[CreateDate]) AND (264.18113618722[MonoisotopicMass] : 264.18641986278[MonoisotopicMass]) 
Tetracycline (0000 : 2011/12[CreateDate]) AND (444.148824225342[MonoisotopicMass] : 444.157707290658[MonoisotopicMass]) 
Tetramisole (0000 : 2006/02[CreateDate]) AND (204.070078364809[MonoisotopicMass] : 204.074159807191[MonoisotopicMass]) 
Theobromine (0000 : 2006/02[CreateDate]) AND (180.062924874745[MonoisotopicMass] : 180.066526169255[MonoisotopicMass]) 
Thiethylperazine (0000 : 2006/02[CreateDate]) AND (399.176297523107[MonoisotopicMass] : 399.184281128893[MonoisotopicMass]) 
Thioridazine (0000 : 2006/02[CreateDate]) AND (370.150038687598[MonoisotopicMass] : 370.157441762402[MonoisotopicMass]) 
Thiothixene (0000 : 2006/02[CreateDate]) AND (443.165686869814[MonoisotopicMass] : 443.174550272186[MonoisotopicMass]) 
Thonizide (0000 : 2006/02[CreateDate]) AND (511.432473032126[MonoisotopicMass] : 511.442701783874[MonoisotopicMass]) 
Tripelennamine (0000 : 2006/02[CreateDate]) AND (255.170995954523[MonoisotopicMass] : 255.176099425477[MonoisotopicMass]) 




Author Hill et al.41) Wolf et al.
42) 
(MetFrag) 




Product Ion Spectrum Selected Merged Merged Merged 
4-Aminoantipyrine 16 18 76 3 
6a-Methylprednisolone 11 4 8 7 
Acepromazine 4 7 2 2 
Acetophenazine 1 2 2 2 
Adenosine_Diphosphate 3 3 2 2 
Adiphenine 6 4 5 8 
Albuterol 15 35 13 12 
Alfentanil 1 1 1 1 
Amfenac 11 25 10 2 
Aminophylline 21 3 29 5 
Ampicillin 1 11 3 2 
Anileridine 251 3 9 2 
Antipyrine 97 104 172 233 
Apomorphine 12 11 6 5 
Apramycin 1 1 1 1 
Betaxolol 5 2 5 1 
Boldenone_Undecylenate 2 2 1 8 
Bumetanide 10 1 1 41 
Buprenorphine 2 9 3 1 
Buspirone 1 2 1 1 
Cholesterol 52 42 20 26 
Cromolyn 2 4 4 3 
Cymarin 8 8 8 1 
Daunorubicin 12 5 7 7 
Dextromethorphan 23 22 60 19 
Dihydroergotamine 1 1 1 4 
Dimefline 644 195 156 5 
Diphenoxylate 4 1 1 44 
Dobutamine 44 7 3 8 
Doxorubicin 3 7 5 7 
Drofenine 4 6 3 1 
Enalapril 1 5 2 1 
Enalaprilat 2 12 1 2 
Ephedrine 5 8 5 47 
Ergocristine 1 10 2 7 
Ergoloid_Mesylate 1 1 1 2 
Etamiphylline 3 1 11 1 
Etodolac 1 1 5 1 
Fenbendazole 92 9 1 88 
Fenoterol 5 2 3 3 
Folic_Acid 13 4 3 1 
Gallamine 1 1 1 1 
Gingerol 2 2 2 1 
Hematoporphyrin_I 33 11 24 4 
Hydrocortisone 4 7 7 9 
Hydroxybutorphanol 2 1 31 19 
Hydroxyphenethylamine 166 32 3 6 
Isoxsuprine 5 15 2 2 
Ketorolac 37 13 132 73 
Leucine_Enkephalin 2 1 1 2 
Mebeverine 2 2 2 2 
Mefenamic_Acid 328 125 99 18 
Meprobamate 19 8 8 6 
Methionine_Enkephalin 1 1 1 1 
Methotrexate 116 5 5 7 
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Table S-2??????????????????? (??) 
Author Hill et al.41) Wolf et al.
42) 
(MetFrag) 




Methylergonovine 1 1 1 9 
Morphine-3-Glucuronide 2 38 13 3 
Naltrexone 34 18 333 48 
Nandrolone 18 14 36 21 
Nimesulide 136 6 1 70 
Norpropoxyphene 15 5 1 11 
Noscapine 3 55 37 1 
Ormetoprim 124 197 36 4 
Oxaprozin 101 98 189 6 
Oxybutynin 6 1 1 1 
Oxycodone 102 26 179 84 
Oxytetracycline 4 1 2 5 
Perindopril 2 3 2 1 
Piperacetazine 1 1 1 1 
Poldine 19 6 - not assigned 
Prazosin 4 17 2 2 
Prednisolone 13 3 8 16 
Prednisolone_Tebutate 4 3 6 1 
Prednisone 6 8 14 21 
Prolintane 9 18 4 3 
Pyrilamine 1 6 1 1 
Remifentanil 1 1 1 1 
Reserpine 3 11 3 2 
Rolitetracycline 1 1 1 3 
Salmeterol 1 2 1 1 
Spectinomycin 1 1 2 1 
Streptomycin 1 5 3 1 
Strychnine 575 188 344 245 
Strychnine_N-oxide 1098 734 816 2 
Sufentanil 1 1 1 1 
Sulfadimethoxine 18 3 3 5 
Sulfasalazine 5 3 4 8 
Taurocholate 4 3 4 4 
Tenoxicam 1 1 1 6 
Terbutaline 31 24 8 11 
Terfenadine 1 2 1 2 
Testosterone_Propionate 3 7 9 3 
Tetracaine 22 1 1 1 
Tetracycline 5 1 5 17 
Tetramisole 1 79 2 57 
Theobromine 14 20 32 21 
Thiethylperazine 2 2 1 7 
Thioridazine 1 1 1 1 
Thiothixene 1 1 1 1 
Thonizide 1 1 - 1 
Tripelennamine 3 4 1 1 
Vecuronium 1 1 1 1 
Average: 44.2 (+/- 14.1) 24 (+/- 7.9) 30.8 (+/- 9.8) 14.7 (+/- 3.6) 
Std. Deviation 142.5 80.2 98.9 36.6 
25% Quartile 1 1 1 1 
Median 4 4.5 3 3 




Author Hill et al.41) Wolf et al.
42) 
(MetFrag) 




Product Ion Spectrum Selected Merged Merged Merged 
4-Aminoantipyrine 226 271 227 221 
6a-Methylprednisolone 226 296 183 176 
Acepromazine 281 338 271 271 
Acetophenazine 435 546 402 408 
Adenosine_Diphosphate 32 46 32 31 
Adiphenine 623 796 594 577 
Albuterol 143 205 131 213 
Alfentanil 134 162 82 158 
Amfenac 344 380 292 279 
Aminophylline 94 176 81 61 
Ampicillin 615 780 581 560 
Anileridine 563 668 507 514 
Antipyrine 306 341 289 282 
Apomorphine 453 613 428 411 
Apramycin 54 60 52 50 
Betaxolol 190 259 177 175 
Boldenone_Undecylenate 21 32 21 20 
Bumetanide 619 768 583 569 
Buprenorphine 40 49 36 32 
Buspirone 36 31 15 20 
Cholesterol 52 79 51 41 
Cromolyn 33 37 33 30 
Cymarin 61 84 56 43 
Daunorubicin 110 129 99 95 
Dextromethorphan 166 238 144 137 
Dihydroergotamine 35 38 34 31 
Dimefline 644 876 566 534 
Diphenoxylate 333 369 314 292 
Dobutamine 447 643 395 385 
Doxorubicin 60 81 56 55 
Drofenine 117 148 104 104 
Enalapril 246 286 325 177 
Enalaprilat 370 454 180 312 
Ephedrine 246 307 241 243 
Ergocristine 16 26 14 15 
Ergoloid_Mesylate 7 10 7 7 
Etamiphylline 100 104 47 43 
Etodolac 420 580 372 366 
Fenbendazole 403 480 383 378 
Fenoterol 370 521 317 308 
Folic_Acid 602 824 542 568 
Gallamine 10 8 2 7 
Gingerol 182 195 141 131 
Hematoporphyrin_I 42 47 40 39 
Hydrocortisone 260 301 208 209 
Hydroxybutorphanol 180 201 138 34 
Hydroxyphenethylamine 166 173 165 166 
Isoxsuprine 447 643 395 37.5 
Ketorolac 344 380 292 279 
Leucine_Enkephalin 53 60 49 51 
Mebeverine 96 112 84 78 
Mefenamic_Acid 579 633 519 512 
Meprobamate 85 84 75 76 
Methionine_Enkephalin 66 68 56 55 
Methotrexate 644 763 592 585 
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Table S-3???????????????????? (??) 
Author Hill et al.41) Wolf et al.
42) 
(MetFrag) 




Methylergonovine 515 629 442 468 
Morphine-3-Glucuronide 179 171 119 102 
Naltrexone 1035 1418 905 878 
Nandrolone 124 129 87 84 
Nimesulide 136 148 131 122 
Norpropoxyphene 392 476 373 352 
Noscapine 275 364 241 222 
Ormetoprim 270 317 252 238 
Oxaprozin 461 607 437 426 
Oxybutynin 114 156 81 80 
Oxycodone 776 993 726 695 
Oxytetracycline 483 614 446 1511 
Perindopril 102 119 52 55 
Piperacetazine 494 626 382 434 
Poldine 682 495 321 not assigned 
Prazosin 185 204 138 141 
Prednisolone 269 363 215 211 
Prednisolone_Tebutate 143 165 141 130 
Prednisone 344 418 308 296 
Prolintane 105 118 105 96 
Pyrilamine 268 294 255 247 
Remifentanil 246 286 180 177 
Reserpine 28 31 25 23 
Rolitetracycline 105 151 93 454 
Salmeterol 32 37 24 22 
Spectinomycin 310 361 280 274 
Streptomycin 37 43 29 30 
Strychnine 664 882 641 589 
Strychnine_N-oxide 1185 1672 932 1088 
Sufentanil 445 512 397 403 
Sulfadimethoxine 94 145 111 86 
Sulfasalazine 106 116 106 95 
Taurocholate 59 65 54 47 
Tenoxicam 28 34 26 109 
Terbutaline 175 225 168 162 
Terfenadine 34 35 31 29 
Testosterone_Propionate 134 183 103 89 
Tetracaine 308 362 301 291 
Tetracycline 529 673 394 1570 
Tetramisole 120 123 113 105 
Theobromine 94 176 81 82 
Thiethylperazine 569 671 503 473 
Thioridazine 849 1091 736 760 
Thiothixene 726 909 686 630 
Thonizide 4 4 2 4 
Tripelennamine 97 102 93 92 
Vecuronium 3 4 1 1 
Average: 272.2 (+/- 24.2) 338.4 (+/- 31.5) 238.1 (+/- 21.2) 256.7 (+/- 28.1) 
Std. Error 24.2 31.5 21.2 28.1 
Std. Deviation 244.2 318.2 214.6 283.9 
25% Quartile 94 102.5 60.75 55 
Median 183.5 231.5 166.5 166 
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